[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353841-105":59,"doc-detail-353841-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-molecular-insights-into-epidemiological-genetic-and-metabolic-risk-factors-of-gallbladder-cancer-biomarkers-therapeutic-targeting-and-future-perspectives","Integrative Molecular Insights Into Epidemiological, Genetic, and Metabolic Risk Factors of Gallbladder Cancer - Biomarkers, Therapeutic Targeting, and Future Perspectives","","Gallbladder cancer (GBC) is a rare but highly aggressive biliary malignancy with a five-year survival rate below 5%, driven by asymptomatic onset and limited early diagnostics. Epidemiological and genetic findings describe multiple risk factors, yet the molecular links to tumor initiation and progression remain unclear. This review synthesizes evidence connecting geographic, genetic, environmental, inflammation, and infection factors to metabolic and molecular dysregulation, emphasizing metabolic reprogramming and dysregulated signaling and redox balance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-molecular-insights-into-epidemiological-genetic-and-metabolic-risk-factors-of-gallbladder-cancer-biomarkers-therapeutic-targeting-and-future-perspectives/353841/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-molecular-insights-into-epidemiological-genetic-and-metabolic-risk-factors-of-gallbladder-cancer-biomarkers-therapeutic-targeting-and-future-perspectives/353841.png","ImageObject",300,407,{"name":92,"@type":93},"Ophelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is gallbladder cancer often detected late?","Question",{"text":112,"@type":113},"GBC typically begins without clear symptoms and lacks reliable early diagnostic tools, so many cases are diagnosed at advanced stages.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which risk-factor categories does the review connect to GBC?",{"text":117,"@type":113},"The review integrates geographic variation, genetic predisposition, environmental exposures, chronic inflammation, and infections, linking them to tumor initiation and progression.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does metabolism play in the proposed mechanism of GBC?",{"text":121,"@type":113},"Metabolic reprogramming is described as a central driver, with altered lipid metabolism, bile acid signaling, and redox imbalance interacting with inflammatory and oncogenic pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353841,1790917389,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Integrative Molecular Insights Into Epidemiological, Genetic, and Metabolic Risk Factors of Gallbladder Cancer: Implications for Biomarkers, Therapeutic Targeting, and Future Perspectives  \nCancer Control Volume 33: 1–27 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)  \n[DOI: 10.1177/10732748261433619](DOI: 10.1177/10732748261433619)  \n[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)  \nDeeptima Jaiswar1,2, Vinay Jeeyar1 , Soham Choudhury1,2, and Manjusha Dixit1,2  \nAbstract  \nGallbladder cancer (GBC) is a rare yet highly aggressive malignancy of the biliary tract, characterized by a five-year survival rate of less than 5% . Its asymptomatic onset and the lack of reliable early diagnostic tools contribute to delayed detection and poor clinical outcomes. Although epidemiological and genetic studies have identified numerous risk factors, the molecular mechanisms linking these factors to tumor initiation and progression remain incompletely understood. This review integrates current evidence on the multifactorial etiology of GBC—including geographic variation, genetic predisposition, environmental exposures, chronic inflammation, and infections—with emerging insights into metabolic and molecular dysregulation. Particular focus is placed on metabolic reprogramming as a central driver of carcinogenesis. Altered lipid metabolism, bile acid signaling, and redox imbalance interact with inflammatory and oncogenic pathways, fostering a permissive microenvironment for malignant transformation. Key molecular cascades include inflammationdriven NF-κB activation, bile acid–induced oxidative stress, PI3K/AKT-mediated metabolic remodeling, and DNA damage and repair defects. By consolidating diverse epidemiological and mechanistic data into a unified molecular–metabolic framework, this narrative review identifies new opportunities for biomarker discovery, metabolic imaging, early detection, and targeted therapeutic development, advancing translational research to improve outcomes in this devastating disease.  \nPlain Language Summary  \nGallbladder cancer (GBC) is a rare but highly aggressive cancer that is often diagnosed too late for effective treatment. Many factors can increase the risk of developing GBC, including gallstones, chronic infections, lifestyle habits, and inherited genetic changes. This review explains how these different risk factors may work together to trigger cancer through changes in cell metabolism and molecular pathways. We describe how long-term inflammation, bile and lipid imbalance, and exposure to infections or toxins can damage cells and alter key biological processes such as energy use, signaling, and DNA repair. These disruptions can lead to uncontrolled growth and tumor development. By combining evidence from population studies and molecular research, our review highlights possible links between risk factors and metabolic changes that drive cancer. Understanding these connections may help identify early warning biomarkers and develop targeted treatments for GBC in the future.  \n1School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, Odisha, India 2Homi Bhabha National Institute, BARC Training School Complex, Mumbai, Maharashtra, India  \nCorresponding author:  \nDr. Manjusha Dixit, Room No. 204, School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, PO: Jatani, Khurda, Odisha, India, Pincode: 752050.  \n[Email:](Email: manjusha@niser.ac.in)[ manjusha@niser.ac.in](Email: manjusha@niser.ac.in)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided th","cbCaiuCxzv9OTey7","https://ap.wps.com/l/cbCaiuCxzv9OTey7","pdf",4941665,27,"English","# Abstract\n# Plain Language Summary\n# Keywords\n# Introduction\n## Disease burden and prognosis\n## Diagnostic challenges and treatment resistance\n## Geographic variation and incidence trends\n## Multifactorial etiology and risk factors","[{\"question\":\"Why is gallbladder cancer often detected late?\",\"answer\":\"GBC typically begins without clear symptoms and lacks reliable early diagnostic tools, so many cases are diagnosed at advanced stages.\"},{\"question\":\"Which risk-factor categories does the review connect to GBC?\",\"answer\":\"The review integrates geographic variation, genetic predisposition, environmental exposures, chronic inflammation, and infections, linking them to tumor initiation and progression.\"},{\"question\":\"What role does metabolism play in the proposed mechanism of GBC?\",\"answer\":\"Metabolic reprogramming is described as a central driver, with altered lipid metabolism, bile acid signaling, and redox imbalance interacting with inflammatory and oncogenic pathways.\"}]","Integrative Molecular Insights Into Epidemiological, Genetic, and Metabolic Risk Factors of Gallbladder Cancer - Biomarkers, Therapeutic Targeting, and Future Perspectives | PDF",1790107500,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43e4203d187eb2dad954e088338122bf.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee015ac5c81794b77380ec34b7255718.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c46422721e90b5dc2a7ab93e52dbcd2.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d95c4c5f8075707625fe53f1e12cfa3c.webp",980,1306]